Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Part of paid clinical trials in Livingston, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT05296421
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biopsy — PROCEDUREUndergo biopsy
- Therapeutic Conventional Surgery — PROCEDUREUndergo surgery
- Uniformly-labeled [13C]glucose — OTHERGiven IV
Study Details
This clinical trial investigates the nutrients pancreatic cancers depend on in which to survive and the processes these tumors use (metabolism) to obtain these nutrients. Giving U-13C-glucose during surgery may allow doctors to trace the metabolic activity of pancreatic cancer in research experiments done in the laboratory. These experiments may help researchers understand how cancer cells manage their nutrients when compared to normal pancreatic cells.
Key Dates
- Start date
- Mar 14, 2022
- Status verified
- Apr 2026
- Primary completion
- Mar 1, 2027
- Completion
- Jul 1, 2027
Study Design
- Enrollment
- 16 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Basic science (uniformly-labeled [13C]glucose)Patients receive uniformly-labeled \[13C\]glucose IV over 10 minutes and then over up to 120 minutes until time of biopsy. Patients then undergo surgery and biopsy per standard of care.
Primary Outcome Measure
To measure glycolysis metabolism dependencies via liquid chromatography-mass spectrometry (LC-MS) [ Time Frame: Up to 2 years ]
Central Contacts
- Howard Hochster, MD732-235-5912
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cooperman Barnabas Medical Center (Saint Barnabas Medical Center) | Livingston | New Jersey | 07039 | - |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | Howard S. Hochster 732-235-5912 Howard S. Hochster (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Livingston, NJ
By condition
By specialty
Related Studies
- Pancreatic Cancer Early Detection ConsortiumRecruiting · Arbor Research Collaborative for Health · Phoenix, Arizona
- Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsPHASE1 · Recruiting · Radiopharm Theranostics, Ltd · Princeton, New Jersey
- A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung CancerPHASE2 · Recruiting · Georgetown University · Washington D.C., District of Columbia